Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trialPedro M. Folegatti, Alexander Batten, Christina Dold et al.|The Lancet|2020Cited by 2.6k
Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analysesLola Madrid, Vinod K. Paul, Anna C. Seale et al.|Clinical Infectious Diseases|2017Cited by 453
Neurodevelopmental Impairment in Children After Group B Streptococcal Disease Worldwide: Systematic Review and Meta-analysesMaya Kohli-Lynch, Joy E Lawn, Neal Russell et al.|Clinical Infectious Diseases|2017Cited by 210
Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infantsShabir A. Madhi, Peter Dull, Ziyaad Dangor et al.|Vaccine|2013Cited by 132
C-Reactive Protein, Procalcitonin, and White Blood Count to Rule Out Neonatal Early-onset Sepsis Within 36 Hours: A Secondary Analysis of the Neonatal Procalcitonin Intervention StudyMartin Stocker, Annemarie M. C. van Rossum, Wendy van Herk et al.|Clinical Infectious Diseases|2020Cited by 116